For this case - some competition data. Amtagvi, is built from a type of immune cells known as tumor-infiltrating lymphocytes, or TILs Although not the same tech as ours - this is what happens to the share price and what we frankly can expect - Iovance received FDA approval for their product recently based on phase 2 trials……the cost for the patient is about $510+ per treatment (stand to be corrected here Additionally- the product comes with a “black box” warning….
Education and theories, page-21
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.2¢ |
Change
-0.001(1.89%) |
Mkt cap ! $382.1M | |||
| Open | High | Low | Value | Volume |
| 5.3¢ | 5.4¢ | 5.2¢ | $216.1K | 4.106M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 31 | 1854997 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 382882 | 4 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |